Patents by Inventor Demetri Spyropoulos

Demetri Spyropoulos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Idetification of neural defects associated with the nucleosomal assembly protien 1l 2 gene
    Publication number: 20040029822
    Abstract: A method for screening neural system defects in a human comprises: (A) providing chromosomal material from the human; (B) detecting a modification of the NAP1L2 gene in the chromosomal material, wherein the modification is selected from a) substitution, b) deletion, c) frame-shift, or d) insertion that causes a loss of biological function in the NAP1L2 gene; and (C) correlating the modification of the gene with a potential for a neural system defect. The method can also be practiced with the mouse Nap1l2 gene.
    Type: Application
    Filed: July 15, 2003
    Publication date: February 12, 2004
    Inventors: Philip Avner, Christine Rogner Ute, Demetri Spyropoulos, Claire Rougeulle
  • Identification of neural defects associated with the nucleosomal assembly protein 112 gene
    Publication number: 20030148274
    Abstract: A method for screening neural system defects in a human comprises: (A) providing chromosomal material from the human; (B) detecting a modification of the NAP1L2 gene in the chromosomal material, wherein the modification is selected from a) substitution, b) deletion, c) frame-shift, or d) insertion that causes a loss of biological function in the NAP1L2 gene; and (C) correlating the modification of the gene with a potential for a neural system defect. The method can also be practiced with the mouse Nap1l2 gene.
    Type: Application
    Filed: May 3, 2001
    Publication date: August 7, 2003
    Inventors: Ute Rogner, Demetri Spyropoulos, Claire Rougeulle, Philip R. Avner
  • Identification of neural defects associated with the nucleosomal assembly protein 112 gene
    Publication number: 20020102566
    Abstract: A method for screening neural system defects in a human comprises: (A) providing chromosomal material from the human; (B) detecting a modification of the NAP1L2 gene in the chromosomal material, wherein the modification is selected from a) substitution, b) deletion, c) frame-shift, or d) insertion that causes a loss of biological function in the NAP1L2 gene; and (C) correlating the modification of the gene with a potential for a neural system defect. The method can also be practiced with the mouse Nap1l2 gene.
    Type: Application
    Filed: May 3, 2001
    Publication date: August 1, 2002
    Inventors: Ute Rogner, Demetri Spyropoulos, Claire Rougeulle, Philip R. Avner